Ciaramella Giuseppe 4
4 · Beam Therapeutics Inc. · Filed Apr 2, 2026
Research Summary
AI-generated summary of this filing
Beam Therapeutics (BEAM) President Giuseppe Ciaramella Receives RSU Award
What Happened
Giuseppe Ciaramella, President of Beam Therapeutics, was granted 40,000 restricted stock units (RSUs) on March 31, 2026. The Form 4 reports the acquisition price as $0.00 (an award/grant), so no cash purchase occurred. Each RSU represents the contingent right to one share of BEAM common stock; the award will convert to shares as it vests.
Key Details
- Transaction date: 2026-03-31; transaction type: Award/Grant (code A).
- Units granted: 40,000 RSUs; reported acquisition price: $0.00.
- Shares owned after transaction: Not specified in the filing.
- Footnote: RSUs vest in four substantially equal installments on each of the first four anniversaries of the grant date, subject to continued service (see F1).
- Filing status: Form filed 2026-04-02; no late filing indicated in the report.
Context
RSU grants are a common form of executive compensation and vest over time, aligning management with shareholder interests as shares are delivered at vesting. Because this was an award (not an open-market purchase or sale), it does not represent an immediate cash investment or liquidation by the insider.
Insider Transaction Report
- Award
Common Stock
[F1]2026-03-31+40,000→ 230,216 total
Footnotes (1)
- [F1]Represents restricted stock units ("RSUs") granted to the Reporting Person under the Beam Therapeutics Inc. ("BEAM") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSUs vest in four substantially equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date.